Terms: = Kidney tumors AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
203 results:
1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract] [Full Text] [Related]
2. prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract] [Full Text] [Related]
3. Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF).
Ye X; Tuo Z; Chen K; Wu R; Wang J; Yu Q; Ye L; Miyamoto A; Yoo KH; Zhang C; Wei W; Li D; Feng D
Oncol Res; 2024; 32(3):503-515. PubMed ID: 38361753
[TBL] [Abstract] [Full Text] [Related]
4. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
5. Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma.
Chen SA; Zhang JP; Wang N; Chen J
Technol Cancer Res Treat; 2023; 22():15330338231194555. PubMed ID: 38043946
[TBL] [Abstract] [Full Text] [Related]
6. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage.
Uno K; Rastegar B; Jansson C; Durand G; Valind A; Chattopadhyay S; Bertolotti A; Ciceri S; Spreafico F; Collini P; Perotti D; Mengelbier LH; Gisselsson D
Mod Pathol; 2024 Jan; 37(1):100382. PubMed ID: 37951357
[TBL] [Abstract] [Full Text] [Related]
7. p53, CK20, and FGFR3 Overexpression is Associated with the Characteristics of Urothelial Cell Carcinoma of the Bladder.
Asgari M; Firouzi F; Abolhasani M; Bahadoram M; Barahman M; Madjd Z; Mehrazam M; Hassanzadeh S; Akade E
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3125-3131. PubMed ID: 37774064
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology.
Kobayashi G; Hayashi T; Sentani K; Uraoka N; Fukui T; Kido A; Katsuya N; Ishikawa A; Babasaki T; Sekino Y; Nose H; Hinata N; Oue N
Pathol Int; 2023 Sep; 73(9):444-455. PubMed ID: 37589430
[TBL] [Abstract] [Full Text] [Related]
9. A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation.
Javaid H; Barberis A; Chervova O; Nassiri I; Voloshin V; Sato Y; Ogawa S; Fairfax B; Buffa F; Humphrey TC
BMC Cancer; 2023 Aug; 23(1):721. PubMed ID: 37528416
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical expression of p53 protein in nephroblastoma: a predictor of unfavorable prognosis.
Morgan ED; Yahaya JJ; Ngaiza AI; Othieno E; Livex OA
J Egypt Natl Canc Inst; 2023 Jul; 35(1):23. PubMed ID: 37518096
[TBL] [Abstract] [Full Text] [Related]
11. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of IKBIP in papillary renal cell carcinoma.
Zhang H; Tang R; Wen X; Cai J; Huang J; Luo L; Yang Z
BMC Urol; 2023 Jul; 23(1):121. PubMed ID: 37454079
[TBL] [Abstract] [Full Text] [Related]
13. Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal.
Wei H; Li Z; Zhao Y; Zhu S; Wen S; Quan C
Cancer Rep (Hoboken); 2023 Aug; 6(8):e1824. PubMed ID: 37344930
[TBL] [Abstract] [Full Text] [Related]
14. A risk signature of ubiquitin-specific protease family predict the prognosis and therapy of kidney cancer patients.
Wang R; Liu Y; Li J; Zhao Y; An R; Ma Z
BMC Nephrol; 2023 May; 24(1):153. PubMed ID: 37259026
[TBL] [Abstract] [Full Text] [Related]
15. Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort study.
Myint KZY; Shimabuku M; Horio R; Kaneda M; Shimizu Y; Taguchi J
Cancer Treat Res Commun; 2023; 35():100701. PubMed ID: 37094468
[TBL] [Abstract] [Full Text] [Related]
16. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
17. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
Zhang D; Wang T; Zhou Y; Zhang X
Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
[TBL] [Abstract] [Full Text] [Related]
18. A novel mitochondria-related gene signature in esophageal carcinoma: prognostic, immune, and therapeutic features.
Zhang X; Wu H; Niu J; Hu Y; Zhang W; Chang J; Li L; Zhu J; Zhang C; Liu M
Funct Integr Genomics; 2023 Mar; 23(2):109. PubMed ID: 36991225
[TBL] [Abstract] [Full Text] [Related]
19. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
[TBL] [Abstract] [Full Text] [Related]
20. Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in MDS.
Pan D; Zhao W; Jiang Q; Yin C; He H; Liao L; Ye J; Dai M
Leuk Lymphoma; 2023 Apr; 64(4):856-864. PubMed ID: 36905177
[TBL] [Abstract] [Full Text] [Related]
[Next]
